SCHEMBL12217604

SCHEMBL12217604

CCN1CCN(C(=O)c2ccc(O)c(C)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ HPGD P15428 3/20 0.51
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ DUSP3 P51452 2/20 0.50
▸ PTPN7 P35236 1/20 0.50
▸ NPBWR1 P48145 1/20 0.48
▸ HSP90AA1 P07900 1/20 0.48
▸ HSP90AB1 P08238 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ PTPN5 P54829 1/20 0.48
▸ PTPN11 Q06124 1/20 0.48
▸ BLM P54132 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12217749 0.86 ALDH1A1 (0.58) ALDH1A1HPGDKMT2ADUSP3HSP90AA1
SCHEMBL2376824 0.84 HPGD (0.55) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL2377858 0.84 GAA (0.55) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL12217821 0.83 KMT2A (0.60) ALDH1A1HPGDKMT2AMEN1HSP90AA1
SCHEMBL3234941 0.83 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL12217587 0.83 HPGD (0.64) ALDH1A1SMN1; SMN2HPGDKMT2ATSHR
SCHEMBL12217590 0.83 HPGD (0.59) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL10242018 0.81 HPGD (0.65) ALDH1A1SMN1; SMN2HPGDKMT2ATSHR
SCHEMBL2377312 0.81 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL10195012 0.80 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2HPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039638-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-18 — — US disclosed
US-8039638-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-18 — — US disclosed
US-20100069353-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-18 — — US disclosed
US-20100069353-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-03-18 — — US disclosed
WO-2008067644-A1 INHIBITORS OF HIV REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-06-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069353-A1 INHIBITORS OF HIV REPLICATION RTF2, REV1, CCNT1 ALDH1A1 3455/4885SMN1; SMN2 4729/4885HPGD 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback